Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Aetna will cover fertility treatments for LGBTQ people under court settlement

Published 05/03/2024, 02:23 PM
Updated 05/03/2024, 05:40 PM
© Reuters. A logo of Aetna is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017.  REUTERS/Lucas Jackson/File Photo
CVS
-

By Daniel Wiessner

(Reuters) - Aetna will pay $2 million and update its coverage policies to settle a lawsuit claiming the health insurer required LGBTQ beneficiaries to pay more out of pocket for fertility treatments than heterosexual people, according to a Friday court filing.

Lawyers for four people who in 2021 sued Aetna, a subsidiary of CVS Health Corp (NYSE:CVS), asked a Manhattan federal court to approve the settlement, in which the company agreed to establish a new standard health benefit plan that covers artificial insemination regardless of sexual orientation.

Previously, Aetna required heterosexual couples simply to represent that they had tried for six or 12 months to get pregnant before covering fertility treatments.

But couples who could not conceive through intercourse first had to pay for treatments out of pocket for up to a year before they were covered, according to court filings.

Aetna denied wrongdoing in the settlement. In a statement, the company said it is "committed to providing quality care to all individuals regardless of their sexual orientation or gender identity and pleased to reach a resolution to this matter."

Under the settlement, Aetna will establish a $2 million fund to reimburse beneficiaries for out-of-pocket expenses they incurred under the old policy. The company also agreed to re-process eligible claims for coverage and modify its clinical policies to ensure equal access to fertility treatments.

Emma Goidel, the lead plaintiff in the case, called the settlement "a big win for queer families" in a statement provided by her lawyers. Goidel claims she and her spouse were forced to spend nearly $45,000 on fertility treatments as a result of Aetna's policy.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A spokeswoman for the National Women's Law Center, which represents Goidel and the other plaintiffs, said that similar discriminatory coverage policies are "an industry-wide problem" and that the group hopes other insurers will follow Aetna's lead.

Latest comments

Alphabet loons ruining the future generations of America. Bring back psych wards.
Could a dog converted to one's own son/daughter be covered?!
I'm 67 yeold. you know my comment!👎
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.